Portal:RareDisease/News

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Current revision (11:40, 4 May 2023) (view source)
 
(11 intermediate revisions not shown.)
Line 1: Line 1:
==== Explore rare disease pathways on WikiPathways: ====
==== Explore rare disease pathways on WikiPathways: ====
 +
 +
Overview table here: [https://classic.wikipathways.org/index.php?title=Special:CurationTags&showPathwaysFor=Curation%3ARareDiseases]
* [[Pathway:WP3584|MECP2 and Associated Rett Syndrome]]
* [[Pathway:WP3584|MECP2 and Associated Rett Syndrome]]
Line 6: Line 8:
* [[Pathway:WP3569|Fanconi Anemia Pathway]]
* [[Pathway:WP3569|Fanconi Anemia Pathway]]
* [[Pathway:WP4298|Viral Acute Myocarditis]]
* [[Pathway:WP4298|Viral Acute Myocarditis]]
-
* [[Pathway:WP4153|Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses]]
+
* [[Pathway:WP4153|Degradation pathway of sphingolipids, including diseases]]
* [[Pathway:WP4540|Pathways Regulating Hippo Signaling]]
* [[Pathway:WP4540|Pathways Regulating Hippo Signaling]]
* [[Pathway:WP4541|po-Merlin Signaling Dysregulation]]
* [[Pathway:WP4541|po-Merlin Signaling Dysregulation]]
* [[Pathway:WP4549|Fragile X Syndrome]]
* [[Pathway:WP4549|Fragile X Syndrome]]
-
* [[Pathway:WP4577|WDR45 autophagy related pathway]]
+
* [[Pathway:WP4577|Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway]]
* [[Pathway:WP3995|Prion disease pathway]]
* [[Pathway:WP3995|Prion disease pathway]]
* [[Pathway:WP3853|ERK Pathway in Huntington's Disease]]
* [[Pathway:WP3853|ERK Pathway in Huntington's Disease]]
Line 18: Line 20:
* [[Pathway:WP4535|Envelope proteins and their potential roles in EDMD physiopathology]]
* [[Pathway:WP4535|Envelope proteins and their potential roles in EDMD physiopathology]]
* [[Pathway:WP4803|Ciliopathies]]
* [[Pathway:WP4803|Ciliopathies]]
-
* [[Pathway:WP4947|NO metabolism in cystic fibrosis]]
+
* [[Pathway:WP4947|Nitric oxide metabolism in cystic fibrosis]]
 +
* [[Pathway:WP5087|Malignant pleural mesothelioma]]
 +
* [[Pathway:WP4804|Cholesterol biosynthesis with skeletal dysplasias]]
 +
* [[Pathway:WP5114|Nucleotide excision repair in xeroderma pigmentosum]]
Laminopathy pathways
Laminopathy pathways
Line 28: Line 33:
CAKUT (congenital anomalies of the kidney and urinary tract)
CAKUT (congenital anomalies of the kidney and urinary tract)
* [[Pathway:WP5053|Development of uretric collection system]]
* [[Pathway:WP5053|Development of uretric collection system]]
-
* [[Pathway:WP4823|Genes controlling renal nephrogenesis]]
+
* [[Pathway:WP4823|Genes controlling nephrogenesis]]
* [[Pathway:WP5052|Nephrogenesis]]
* [[Pathway:WP5052|Nephrogenesis]]
* [[Pathway:WP4830|GDNF/RET signalling axis]]
* [[Pathway:WP4830|GDNF/RET signalling axis]]
 +
 +
Disorders of sex development and fertility
 +
* [[Pathway:WP4673|Genes involved in male infertility]]
 +
* [[Pathway:WP4524|The alternative pathway of fetal androgen synthesis]]
 +
* [[Pathway:WP4814|Somatic Sex determination]]
 +
* [[Pathway:WP4842|Mammalian disorder of sexual development]]
 +
* [[Pathway:WP4871|Kisspeptin/Kisspeptin Receptor System in the Ovary]]
 +
* [[Pathway:WP4835|Peroxiredoxin 2 induced ovarian failure]]
 +
* [[Pathway:WP5074|Kallmann syndrome]]
 +
 +
Copy number variation syndromes (CNVs) - duplications or deletions
 +
* [[Pathway:WP4905|1q21.1 copy number variation syndrome]]
 +
* [[Pathway:WP4906|3q29 copy number variation syndrome]]
 +
* [[Pathway:WP4657|22q11.2 copy number variation syndrome]]
 +
* [[Pathway:WP3998|Prader-Willi and Angelman Syndrome]]
 +
* [[Pathway:WP4932|7q11.23 copy number variation syndrome]]
 +
* [[Pathway:WP4940|15q11.2 copy number variation syndrome]]
 +
* [[Pathway:WP4942|15q13.3 copy number variation syndrome]]
 +
* [[Pathway:WP4950|16p11.2 distal deletion syndrome]]
 +
* [[Pathway:WP4949|16p11.2 proximal deletion syndrome]]
 +
 +
Lipodystrophy, dyslipidemia and hyperlipidemia
 +
* [[Pathway:WP5105|Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia]]
 +
* [[Pathway:WP5108|Familial hyperlipidemia type 1]]
 +
* [[Pathway:WP5109|Familial hyperlipidemia type 2]]
 +
* [[Pathway:WP5110|Familial hyperlipidemia type 3]]
 +
* [[Pathway:WP5111|Familial hyperlipidemia type 4]]
 +
* [[Pathway:WP5112|Familial hyperlipidemia type 5]]
 +
* [[Pathway:WP5104|Acquired partial lipodystrophy / Barraquer-Simons syndrome]]
 +
* [[Pathway:WP5103|Progeria-associated lipodystrophy]]
 +
* [[Pathway:WP5102|Familial partial lipodystrophy (FPLD)]]
 +
* [[Pathway:WP5101|Congenital generalized lipodystrophy (CGL)]]
Inborn errors of metabolism
Inborn errors of metabolism
Line 45: Line 82:
* [[Pathway:WP4156|Disorders of Phenylalanine and Tetrahydrobiopterin]]
* [[Pathway:WP4156|Disorders of Phenylalanine and Tetrahydrobiopterin]]
* [[Pathway:WP4506|Tyrosine Metabolism]]
* [[Pathway:WP4506|Tyrosine Metabolism]]
-
* [[Pathway:WP4292|Sulphur Amino Acids]]
+
* [[Pathway:WP4292|Methionine metabolism leading to sulfur amino acids and related disorders]]
* [[Pathway:WP4259|Disorders of Folate Metabolism and Transport]]
* [[Pathway:WP4259|Disorders of Folate Metabolism and Transport]]
* [[Pathway:WP4288|MTHFR deficiency]]
* [[Pathway:WP4288|MTHFR deficiency]]
Line 60: Line 97:
* [[Pathway:WP5028|Biochemistry of Glycine metabolism]]
* [[Pathway:WP5028|Biochemistry of Glycine metabolism]]
* [[Pathway:WP5026|Biochemistry of Proline and Hydroxyproline]]
* [[Pathway:WP5026|Biochemistry of Proline and Hydroxyproline]]
-
 
+
* [[Pathway:WP4595|Urea cycle and associated pathways]]
-
Disorders of sex development and fertility
+
* [[Pathway:WP5029|Amino acid transport defects]]
-
* [[Pathway:WP4673|Genes involved in male infertility]]
+
* [[Pathway:WP4686|Leucine, isoleucine and valine metabolism]]
-
* [[Pathway:WP4524|The alternative pathway of fetal androgen synthesis]]
+
* [[Pathway:WP5028|Glycine metabolism, including IEMs]]
-
* [[Pathway:WP4814|Somatic Sex determination]]
+
* [[Pathway:WP4157|GABA metabolism (aka GHB)]]
-
* [[Pathway:WP4842|Mammalian disorder of sexual development]]
+
* [[Pathway:WP5026|Proline and hydroxyproline pathways]]
-
* [[Pathway:WP4871|Kisspeptin/Kisspeptin Receptor System in the Ovary]]
+
* [[Pathway:WP4688|Serine metabolism]]
-
* [[Pathway:WP4835|Peroxiredoxin 2 induced ovarian failure]]
+
* [[Pathway:WP5031|Biotin metabolism, including IEMs]]
-
 
+
* [[Pathway:WP5037|Riboflavin and CoQ disorders]]
-
Copy number variation syndromes (CNVs) - duplications or deletions
+
* [[Pathway:WP4971|Phosphoinositides metabolism]]
-
* [[Pathway:WP4905|1q21.1 copy number variation syndrome]]
+
* [[Pathway:WP5030|Ethylmalonic encephalopathy]]
-
* [[Pathway:WP4906|3q29 copy number variation syndrome]]
+
-
* [[Pathway:WP4657|22q11.2 copy number variation syndrome]]
+
-
* [[Pathway:WP3998|Prader-Willi and Angelman Syndrome]]
+
-
* [[Pathway:WP4932|7q11.23 copy number variation syndrome]]
+
-
* [[Pathway:WP4940|15q11.2 copy number variation syndrome]]
+
-
* [[Pathway:WP4942|15q13.3 copy number variation syndrome]]
+
-
* [[Pathway:WP4950|16p11.2 distal deletion syndrome]]
+
-
* [[Pathway:WP4949|16p11.2 proximal deletion syndrome]]
+

Current revision

Explore rare disease pathways on WikiPathways:

Overview table here: [1]

Laminopathy pathways

CAKUT (congenital anomalies of the kidney and urinary tract)

Disorders of sex development and fertility

Copy number variation syndromes (CNVs) - duplications or deletions

Lipodystrophy, dyslipidemia and hyperlipidemia

Inborn errors of metabolism

Personal tools